Stockreport

Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate

Windtree Therapeutics, Inc.  (WINT) 
Last windtree therapeutics, inc. earnings: 8/21 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: windtreetx.investorroom.com
PDF Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activators Windtree received recent notification of allowed I [Read more]